IRVINE, Calif.--(BUSINESS WIRE)--Mar. 3, 2016--
Masimo (NASDAQ:
MASI) today announced that its management is scheduled to present at the
37th Annual Raymond James Institutional Investors Conference at The
JW Marriott Grande Lakes in Orlando on Wednesday, March 9, 2016, at 8:40
a.m. Eastern Time. A live audiocast of the presentation will be
available on the Masimo website at www.masimo.com.
A replay of the audiocast will be available following the live
presentation.
About Masimo
Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive
monitoring technologies. Our mission is to improve patient outcomes and
reduce the cost of care by taking noninvasive monitoring to new sites
and applications. In 1995, the company debuted Masimo
SET® Measure-through Motion and Low Perfusion™ pulse oximetry, which has
been shown in multiple studies to significantly reduce false alarms and
accurately monitor for true alarms. The benefits of Masimo SET® have
been proven in more than 100 independent and objective studies and it is
estimated to be used on more than 100 million patients in leading
hospitals and other healthcare settings around the world. In
2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing
noninvasive and continuous monitoring of blood constituents that
previously could only be measured invasively, including total hemoglobin
(SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®),
methemoglobin (SpMet®), and more recently, Pleth Variability Index
(PVI®) and Oxygen Reserve Index (ORI™), in addition to SpO2, pulse rate,
and perfusion index (PI). In 2014, Masimo introduced Root®, an intuitive
open architecture patient monitoring and connectivity platform designed
to speed the pace of innovation and reduce the cost of care. Masimo is
also taking an active leadership role in mHealth with products such as
the Radius-7™ wearable patient monitor and the MightySat™ fingertip
pulse oximeter. Additional information about Masimo and its products may
be found at www.masimo.com.
Masimo, SET, Signal Extraction Technology, Improving Patient Outcome
and Reducing Cost of Care... by Taking Noninvasive Monitoring to New
Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI are
trademarks or registered trademarks of Masimo Corporation
View source version on businesswire.com: http://www.businesswire.com/news/home/20160303005269/en/
Source: Masimo
Masimo
Investors:
Eli Kammerman, 949-297-7077
ekammerman@masimo.com
or
Media:
Irene
Paigah, 858-859-7001
irenep@masimo.com